van der Lubbe, Joan E. M.
Rosendahl Huber, Sietske K.
Vijayan, Aneesh http://orcid.org/0000-0002-2828-5285
Dekking, Liesbeth
van Huizen, Ella
Vreugdenhil, Jessica
Choi, Ying
Baert, Miranda R. M.
Feddes-de Boer, Karin
Izquierdo Gil, Ana http://orcid.org/0000-0001-9557-1807
van Heerden, Marjolein
Dalebout, Tim J. http://orcid.org/0000-0002-5916-7548
Myeni, Sebenzile K.
Kikkert, Marjolein http://orcid.org/0000-0002-5779-7386
Snijder, Eric J. http://orcid.org/0000-0003-3297-2309
de Waal, Leon
Stittelaar, Koert J.
Tolboom, Jeroen T. B. M.
Serroyen, Jan
Muchene, Leacky
van der Fits, Leslie
Rutten, Lucy http://orcid.org/0000-0002-7363-6822
Langedijk, Johannes P. M. http://orcid.org/0000-0001-8768-0982
Barouch, Dan H.
Schuitemaker, Hanneke http://orcid.org/0000-0001-8563-2266
Zahn, Roland C. http://orcid.org/0000-0003-2822-6231
Wegmann, Frank http://orcid.org/0000-0002-9821-1492
Funding for this research was provided by:
Janssen Pharmaceuticals
Leids Universitair Medisch Centrum
Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, The Netherlands
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority
Article History
Received: 8 January 2021
Accepted: 16 February 2021
First Online: 19 March 2021
Competing interests
: J.E.M.vdL., S.K.R.H., A.V., L.D., E.vH., J.V., Y.C., M.R.M.B., K.F.-dB., A.I.G., M.vH., J.T.B.M.T., J.S., L.M., L.vdF., L.R., J.P.M.L., D.H.B., H.S., R.C.Z., and F.W. are employees of Janssen Vaccines & Prevention. All authors may own stock or stock options in Johnson & Johnson, the parent company of Janssen Vaccines & Prevention.